Patent 10287359 was granted and assigned to La Trobe University on May, 2019 by the United States Patent and Trademark Office.
The present disclosure provides proteins comprising antibody antigen binding domains that bind to Fn14 and uses thereof. The present disclosure also provides methods for treating wasting disorders, such as cachexia.